MICHAEL V MUENCH
Chiropractic in Point Pleasant Beach, NJ
License number
New Jersey 38MC00385900
Issued Date
Jun 21, 1990
Category
Chiropractic Examiners
Type
Chiropractor
Address
Address
Point Pleasant Beach, NJ
Personal information
See more information about MICHAEL V MUENCH at radaris.comName
Address
Phone
435 Jefferson Ave, Avon By Sea, NJ 07717
288 Highland Rd, South Orange, NJ 07079
435 Jefferson Ave, Avon by the Sea, NJ 07717
2110 County Line Rd, Jackson, NJ 08527
2100 State Route 33, Neptune, NJ 07753
Professional information
See more information about MICHAEL V MUENCH at trustoria.com
Nutritional Supplement For Pregnant Females
Nutritional Supplement For Pregnant Females
US Patent:
2007023, Oct 4, 2007
Filed:
Oct 23, 2006
Appl. No.:
11/552015
Inventors:
Michael V. Muench - Point Pleasant NJ, US
Lori L. Muench - Point Pleasant NJ, US
Steven M. Feld - Loch Arbour (Allenhurst) NJ, US
Lori L. Muench - Point Pleasant NJ, US
Steven M. Feld - Loch Arbour (Allenhurst) NJ, US
International Classification:
A61K 38/43, A61K 31/714, A61K 31/675, A61K 31/525, A61K 31/4415, A61K 31/405, A61K 31/375, A61K 31/415, A61K 31/198, A61K 31/192, A61K 31/616
US Classification:
424 941, 424702, 424643, 514 52, 514165, 514251, 514 89, 514350, 514458, 514763, 514562, 514474, 514419, 514406, 514570
Abstract:
Preeclampsia and intrauterine growth restriction in a pregnant female mammal are prevented or decreased in severity by administering thereto a combination of a vitamin compound containing B1, Folic Acid (or active form 5-Methyl-Tetrahydrofolate i.e.; Metafolin®), B 6 (Pyridoxine or active form Pyridoxine 5-Phosphate P5P), B 12, Ascorbic Acid, Selenium, Zinc, Co-enzyme Q 10 and N-Acytyl Cysteine, Lycopene, optionally in further combination with Melatonin and/or Vitamin E or/and ASA 81 mg both of later, are cyclooxygenase inhibitors, a PGI.sub.2-mimetic, a thromboxane (TXA.sub.2) inhibitor, a compound possessing TXA.sub.2-agonistic and TXA.sub.2-inhibiting properties, a compound possessing TXA.sub.2-antagonistic and PGI.sub.2-mimetic activities, and a TXA.sub.2 antagonist.